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Abstract
Once transcribed, the nascent full-length RNA of HIV-1 must travel to the appropriate host cell sites to be translated or to
find a partner RNA for copackaging to form newly generated viruses. In this report, we sought to delineate the location
where HIV-1 RNA initiates dimerization and the influence of the RNA transport pathway used by the virus on downstream
events essential to viral replication. Using a cell-fusion-dependent recombination assay, we demonstrate that the two RNAs
destined for copackaging into the same virion select each other mostly within the cytoplasm. Moreover, by manipulating
the RNA export element in the viral genome, we show that the export pathway taken is important for the ability of RNA
molecules derived from two viruses to interact and be copackaged. These results further illustrate that at the point of
dimerization the two main cellular export pathways are partially distinct. Lastly, by providing Gag in trans, we have
demonstrated that Gag is able to package RNA from either export pathway, irrespective of the transport pathway used by
the gag mRNA. These findings provide unique insights into the process of RNA export in general, and more specifically, of
HIV-1 genomic RNA trafficking.
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Introduction
HIV-1 full-length RNAs serve at least two functions: as a
template for Gag/Gag-Pol translation, and as genetic material
packaged in the virion. Many cellular factors ensure the correct
macromolecular trafficking between nucleus and cytoplasm;
specifically, mechanisms exist to prevent the export of intron-
containing transcripts, such as the full-length HIV-1 RNA [1,2].
Most cellular mRNAs are fully spliced before export and many are
believed to exit the nucleus via the NXF1-dependent pathway [3].
However, many proteins and some RNAs use an alternative,
CRM-1-dependent pathway to migrate out of the nucleus [3]. The
extent to which these two pathways are linked or overlap is
currently unknown, and the reason for their differential use is
subject to speculation. It is interesting to note that members of the
Retroviridae family can use different transport pathways for the
export of their intron-containing RNA. Some viruses, such as
Mason-Pfizer monkey virus (MPMV), use the NXF1 pathway by
binding the NXF1 protein directly to its RNA via a structured
motif (constitutive transport element or CTE) [4]. Other viruses,
such as HIV-1, use the CRM-1 pathway by indirectly linking the
CRM-1 protein to the viral RNA via a virally encoded protein. In
HIV, the viral protein is Rev and it acts as a bridge between a
structured RNA motif (the Rev-response element (RRE)) and the
CRM-1 protein [5,6]. Additionally, some retroviruses use
pathways that have yet to be identified [7].
Many studies have shown that it is possible to alter the retroviral
RNA transport pathway by manipulating the cis- and trans-acting viral
elements. Interestingly, a recent study indicates that the transport
pathway the RNA takes can influence the function of the protein it
encodes. By altering the transport pathway of the HIV-1 Gag-
encoding RNA from CRM-1 to NXF1, one can relieve the HIV-1
assembly block in murine cells [8]. Intriguingly, Gag was expressed
efficiently in murine cells by RNA using either pathway. However,
efficient assembly only occurred when Gag was translated from RNA
using the NXF1 pathway; Gag translated from the CRM-1 pathway
was mistargeted and could not assemble efficiently [9]. These studies
revealed that the transport pathway may play a far more intricate role
during viral replication than we previously realized.
Retroviruses package two copies of full-length RNA in one virion.
One of the consequences of packaging two RNAs is frequent
recombination during DNA synthesis when reverse transcriptase uses
parts of both RNAs as templates [10,11]. Although frequent
recombination can occur during DNA synthesis of all virions, a
genotypically different recombinant can only be generated from
virions that package two different RNAs (heterozygous virions) [10].
Using a recombination assay, we have shown that RNA molecules
derived from two similar HIV-1 proviruses can randomly assort and
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virions are formed less efficiently when the two proviruses contain
variations in their dimerization initiation signal (DIS). Located at the
loop of stem-loop 1 of the 59 untranslated region, the DIS is a 6-nt
palindromic sequence that forms the initial interaction between the
two HIV-1 RNAs [14]. The Gag polyproteinsof HIV-1 interact with,
and specifically package, the viral RNA to generate infectious viruses.
We have previously examined whether RNA dimerization occurs
prior to virus assembly using HIV-1 variants with DIS mutations that
abolish their palindromic nature (for example, from GCGCGC to
GGGGGG) but can form perfect basepairs with the DIS of a partner
virus (such as a virus with CCCCCC at the DIS).Wereasoned that in
the coinfected cells if dimeric RNAs are packaged, then the
GGGGGG viral RNA would preferentially pair with CCCCCC
viral RNA, and we would therefore observe an increase in the
formation of heterozygous virions. In contrast, if two monomeric
RNAs are packaged, then we would not observe an increase in
heterozygous viruses. Our results revealed that most of the virions
from coinfected cells were heterozygous, indicating that copackaged
RNA partner selection, i.e. dimerization, occurred prior to the
packaging of virion RNA [15].
Many questions remain concerning how HIV-1 full-length
RNA traffics through the cell to fulfill its various roles. For
example, it has been unclear at which point along the RNA
trafficking pathway, from the site of transcription to the site of viral
budding, HIV-1 RNA selects its copackaged RNA to initiate the
dimerization process. It remained unclear whether HIV-1 RNAs
are dimerized in the nucleus and traffic out of the nucleus as a
dimer, or exit the nucleus as a monomer and dimerize in the
cytoplasm. Furthermore, it is not known whether the RNA
transport pathway used by the viral RNA affects its interactions
with other viral RNA or Gag proteins, and thereby influences the
abilities of the RNA to dimerize and be packaged into a nascent
virion. In this current work, we addressed these questions by using
three systems: a cell-fusion-dependent recombination assay to
establish the cellular location of the dimerization event, a Rev-
independent HIV-1 to investigate the influence of the NXF1 and
CRM-1 export pathways on these processes, and a single virion
visualization assay to directly analyze the RNA content of each
viral particle. These studies resulted in three novel findings. We
demonstrate that the majority of HIV-1 RNA dimerization occurs
within the cytoplasm, not within the nucleus. Moreover, the RNA
transport pathway taken by the viral RNA has a major effect on
the ability of the RNA to be copackaged; these results revealed
that RNAs trafficking through the CRM-1 and NXF1 transport
pathways are partially separated at least at the stage of RNA
commitment to dimerization. Finally, we demonstrate that
although the RNA pathways are partially distinct at the point
when initial dimerization occurs, selection of packaged RNA by
Gag does not discriminate between RNA in these two pathways.
These findings provide insights into the mechanisms of HIV
replication including RNA-RNA and RNA-Gag interactions, and
demonstrate a new approach to the unraveling of the detailed
mechanisms of the cell’s nuclear-cytoplasmic trafficking pathways.
Results
The Cellular Location of HIV-1 RNA Partner Selection and
Initial Dimerization
Our previous experiment revealed that the selection of the
copackaged RNA occurs prior to encapsidation into the virion
[15]. In the current study, we sought to determine the subcellular
location where RNA-RNA interactions take place to initiate the
dimerization process. To do this, we developed a cell fusion-based
recombination assay to examine whether RNA partner selection is
initiated in the cytoplasm. Our previously established recombination
assay uses dual-infected cell lines to provide accurate and
reproducible measurements of recombination between two viruses
[13]. In this system, the near-full-length HIV-1 genome encodes two
markers in nef, an inactivated green fluorescent protein gene (gfp)a n d
a second gene that is either a mouseheat-stable antigen gene (hsa)o ra
mouse thy1.2 gene (thy) (Fig. 1). The two inactivating mutations of gfp
Author Summary
High genetic diversity of HIV-1 presents a difficult barrier
for drug treatment and vaccine development. HIV-1
efficiently reassorts mutations in its genome by packaging
two copies of RNA into one virion and using portions of
each RNA as the template for DNA synthesis. Thus, a key to
HIV-1’s genetic diversity is how it packages two RNAs into
one virion. We have previously shown that HIV-1 packages
RNA as a dimer, rather than two monomers. In this report,
we determined that HIV-1 RNA finds its copackaged dimer
partner mostly in the cytoplasm, not the nucleus, of the
infected cells. We also found that the host cell machinery
used to transport the HIV-1 RNA out of the nucleus affects
the ability of two RNAs to copackage into one virion: HIV-1
RNAs transported using the CRM-1 pathway does not
copackage efficiently with RNA transported by the NXF1
pathway. This is also the first demonstration that RNAs
transported by the two major cellular pathways, CRM-1
and NXF1, are partially segregated at some point in the
cytoplasm. Therefore, this work provides novel insights to
both HIV replication mechanisms and cellular RNA
transport pathways.
Figure 1. General structures of the viruses used in the
recombination and packaging assays. H0-RRE is shown on top
and elements of other viruses different from H0-RRE are labelled. Two
marker genes are located in nef of each virus; the translation of the gfp
gene was directed by IRES. The inactivating mutations in gfp are shown
as asterisks. Black box represents the HIV-1 RRE, whereas gray box
represents four copies of MPMV CTE.
doi:10.1371/journal.ppat.1000627.g001
HIV-1 RNA Trafficking and Dimerization
PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000627in these two viruses are separated by a distance of 600 bp. A
proportion of the viral particles released from the dual-infected cell
lines contain one RNA from each provirus (heterozygous viruses);
recombination between which can occur during reverse transcription
to generate a recombinant progeny expressing a functional gfp.T h e
multiplicity of infection (MOI) of the GFP
+ events, as a percentage of
the total infection MOI (determined using the expression ofHSA and
Thy),providesameasureoftherecombinationefficiencybetweenthe
two viruses. As retroviral recombination occurs between two
copackaged RNAs, the rate of recombination is dependent on the
formation of heterozygous virions; therefore, recombination can be
used as a measurement of the dimerization efficiency between two
viral RNAs, as we have previously shown [15].
We modified the recombination system to examine whether we
could detect cytoplasmic RNA dimerization events (Fig. 2). In this
system, two cell lines are generated, each infected with a gag mutant
virus that has a severe replication defect. When the two cell lines are
fused using conditions that facilitate cytoplasmic but not nuclear
fusion, the Gag proteins from these two viruses can coassemble and
complement each other’s function to rescue virus replication. Our
previous study demonstrated that HIV-1 RNA dimerization occurs
prior to Gag packaging [15], and we envision two differential
outcomes that would be reflective of the locations of the dimerization
event (Fig. 2A). If the selection of the copackaged RNA mostly occurs
in the nucleus, the majority of the viruses generated from this system
will contain two RNAs derived from the same provirus (homozygous
virions) that have the same inactivating gfp mutation. Therefore, very
fewGFP
+phenotypes willbe formed by recombination. In contrast, if
the selection of the copackaged RNA mostly occurs in the cytoplasm,
fusing the cytoplasm of the two cell lines will allow the RNAs derived
from the two nuclei to interact and dimerize prior to packaging by
Gag. In this scenario, heterozygous virions can be formed, which can
generate numerous GFP
+ recombinants. Therefore, in the fusion
experiment, the location of the RNA dimerization event, in the
nucleus or in the cytoplasm, predicts different levels of the
recombinant GFP
+ phenotype.
We generated cell lines containing either a nucleocapsid (NC)
mutant virus (T6-NC*) or a late domain mutant virus (H0-PTAP
–).
The NC* mutation reduces RNA packaging to 5% of wild-type and
abolishes infectivity [16] (Fig. 2B panels II and VI), whereas the
PTAP
– mutation reduces viralbuddingand viraltiter dropsto,2%
of wild type [17,18] (Fig. 2B panels III and VII). To facilitate fusion,
onecellline wasbased onmodified 293T cellsthatexpressCD4and
CCR5 (293T.CC), whereas the other cell line was 293T based and
was transiently transfected, prior to fusion, with a plasmid
expressing CCR5-tropic HIV-1 Env. Viruses were harvested 16 h
after the coculture of the two cell lines; at this time point, cell fusion
but not nuclear fusion was visible by microscopy (Fig. S1 and data
not shown). Target cells were infected with these viruses, and flow
cytometry was performed to measure virus infection and recombi-
nation. Our results (Fig. 2C) demonstrate that the recombination
rates of infectious viruses produced by cell fusion (5–6%) are similar
to that of our standard recombination assay (7%), which uses viruses
produced from cellscontainingtwoproviruses[13]. Toconfirm that
nuclear fusion did not affect the results of this assay, the cyclin-
dependent kinase inhibitor roscovitine was added after mixing the
cell lines. Roscovitine was previously shown, in a detailed study of
HIV-1-directed cell fusion, to prevent nuclear envelope breakdown
and nuclear fusion or karyogamy [19]. We observed similar
recombination rates in samples with or without roscovitine
treatment (Fig. 2C), indicating that nuclear fusion was not a factor
in the high levels of recombination detected. Taken together, these
results indicate that most of the RNA dimerization and partner
selection process occurs in the cytoplasm of the producer cells.
Figure 2. The fusion-dependent recombination assay. (A) An
example of the fusion experiment, with predicted outcomes, is shown
schematically using the H0-PTAP
–-infected 293T.CC cell line (293T.CC.H0-
PTAP
–) and a T6-NC*-infected 293T cell line (293T.T6-NC*). The reciprocal
experiment using 293T.CC.T6-NC* and 293T.H0-PTAP
– was also per-
formed. (B) Representative flow cytometry analyses of target cells
infected with viruses harvested from various fusion experiments. The
cells used in the fusion experiments, from which viruses were harvested,
are indicated above each flow cytometry plot; all 293T cells were
transiently transfected with plasmid expressing HIV-1 Env. The x- and y-
axis show Thy and HSA expression, respectively. Panel I, mock infection;
panel V, positive control, viruses harvested from a producer cell line dual-
infected with H0-PTAP
– and T6-NC*. Panels II, III, VI, and VII, viruses
harvested from fusing one cell line containing a mutant provirus with
another cell line that does not contain any HIV-1 provirus; panels IV and
VIII, viruses harvested from fusing a T6-NC*-containing cell line with an
H0-PTAP
–-containingcell line. (C) Observed recombination rates from the
fusion-based recombination assay with (in gray) or without (in white) the
drug roscovitine. Recombination rates generated using viruses harvested
from dual-infected cells are shown for comparison. Means and standard
deviations generated from three experiments are shown.
doi:10.1371/journal.ppat.1000627.g002
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Recombination
Having demonstrated that the majority of HIV-1 RNA
dimerization occurs within the cytoplasm, we further investigated
whether the pathway of entry into the cytoplasm is important for
RNA dimerization and packaging. To this end, we generated two
HIV-1 variants, H0-CTE and B6-CTE, that use the NXF1, and
not the CRM-1, transport pathway by removing the RRE motif
and replacing it with four copies of the MPMV CTE [20]. H0-
CTE encodes the same HSA and mutated gfp marker as H0-RRE
(Fig. 1); B6-CTE encodes a mouse B7 gene and a gfp that has the
inactivating mutation located at the 39 end of the gene (Fig. 1).
Using positive control viruses with two functional genes, we have
previously showed that the HSA and GFP or Thy and GFP
markers are well-expressed and can be simultaneously detected
efficiently by flow cytometry [13]; we have also examined the B7
and GFP expression and showed these two markers were detected
simultaneously and efficiently by flow cytometry (Fig. S2).
To assess the effect of the nuclear export pathway on HIV-1
RNA dimerization and copackaging, six types of dual-infected cell
lines were generated containing either two RRE-dependent
proviruses (H0-RRE.T6-RRE; H0-RRE.B6-RRE), two CTE-
dependent proviruses (H0-CTE.B6-CTE), or one RRE- and one
CTE-dependent provirus (H0-CTE.T6-RRE, H0-CTE.B6-RRE,
and H0-RRE.B6-CTE). Flow cytometry analyses of the markers
encoded by the two viruses indicated that most of the cells (.90%)
in each cell line express both viruses (data not shown). These cell
lines were transiently transfected with a plasmid expressing HIV-1
Env and the released viruses were used to infect target cells; the
titers generated from these infections are shown in Fig. 3A. In
general, the two proviruses in each cell line generated titers within
two fold of each other; the only notable exception was H0-
RRE.B6-CTE, from which the B6-CTE titer was much lower
than that of H0-RRE. We also measured the recombination rates
generated from these cell lines; results from three experiments are
summarized in Fig. 3B. When two viruses both used the CRM-1
pathway (H0-RRE.T6-RRE and H0-RRE.B6-RRE), recombina-
tion rates were 6.2–6.6%, similar to the previously measured 7%
rate using the H0-RRE.T6-RRE cell line. When both viruses used
the NXF1 pathway (H0-CTE.B6-CTE), the recombination rate
was similar to that of the two RRE viruses; these results indicated
that HIV-1 RNAs from two proviruses both using the NXF1
export pathway can copackage together efficiently. In contrast,
recombination between a CTE-using and an RRE-using HIV-1 is
lower than expected from random mixing of the viral genomes.
The two viruses from H0-CTE.T6-RRE cell lines have similar
titers, and if their RNAs were copackaged together randomly, we
would have expected a 6–7% recombination rate; however only
2.5% of the viruses generated GFP
+ recombinants. Similar low
rates of recombination were also observed in viruses harvested
from H0-CTE.B6-RRE cell line and H0-RRE.B6-CTE cell line.
Therefore, HIV-1 variants separately transported by CRM-1 and
NXF1 pathways recombined less frequently than two variants
using the same pathway, either by CRM-1 or by NXF1. These
results suggest that HIV-1 RNAs exported by the CRM-1 and
NXF1 pathways are not copackaged together efficiently.
Single Virion Analyses of Copackaged HIV-1 RNA
Molecules Transported by CRM-1 or NXF1 Pathways
To directly examine whether RNA exiting the nucleus by
different RNA transport pathways can be copackaged together
efficiently, we analyzed the RNA content of the viral particles.
Utilizing the specific interactions between RNA binding proteins
and RNA secondary structures, we recently developed a method
to simultaneously detect two RNA species in virion at single RNA
molecule sensitivity [21]. This system uses modified HIV-1
genomes that contain the stem-loop sequences, referred to as
MS2SL and BglSL, which are recognized by bacteriophage MS2
coat protein and E. coli antitermination protein BglG, respectively
(Fig. 4A). These HIV-1 genomes also express Gag or a Gag-
cerulean fluorescent protein (CeFP) fusion protein. When these
HIV-1 genomes are coexpressed with the MS2 coat protein fused
to a yellow fluorescent protein (MS2-YFP), or the N-terminal
fragment of BglG fused to a red fluorescent protein (Bgl-mCherry)
(Fig. 4B), the presence of viral RNA can be visualized by the
fluorescent signals. To analyze the virion RNA, plasmids
expressing the MS2SL- or BglSL-containing HIV-1 genomes
were cotransfected with plasmids expressing MS2-YFP or Bgl-
mCherry. Viral particles were harvested and visualized; represen-
tative images are shown in Fig. S3 and summarized in Table 1. In
these experiments, HIV-1 particles are detected by CeFP signals,
whereas RNA molecules are detected by YFP or mCherry signals.
It has been shown that when coexpressed with wild-type Gag,
Gag-GFP fusion protein can coassemble into virus-like particles
Figure 3. Effect of nuclear export pathway on recombination.
(A) Titers of the HSA and Thy, or HSA and B7 viruses generated from
producer cell lines. White bars represent titers of viruses encoding HSA,
whereas black bars represent titers of viruses encoding Thy or B7,
respectively. (B) Observed recombination rates using viruses from each
cell line. Means and standard deviations generated from three
experiments are shown.
doi:10.1371/journal.ppat.1000627.g003
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in all RNA visualization experiments, a pair of nearly-identical
HIV-1 constructs were used, one expressing Gag-CeFP and the
other expressing wild-type Gag; for concise description of these
experiments, only the name of the CeFP-tagged construct is used
in the text.
In agreement with our previous results [21], when Bgl-mCherry
was coexpressed with GagCeFP-BglSL-RRE, most of the CeFP
+
particles also have the mCherry signal (.96%; Table 1, Group 1).
The mCherry signal is specific to the BglSL in the viral RNA
genome; particles derived from HIV-1 with similar structures but
containing MS2SL did not have mCherry signals when coex-
pressed with Bgl-mCherry (Table 1, Group 5). Similarly, MS2-
YFP also specifically labeled the HIV-1 genome with MS2SL at
high efficiency (,95%) but not HIV-1 RNA with Bgl SL (Table 1,
Group 2 and 6, respectively). When we examined particles derived
from HIV-1 genomes using the CTE for export, we observed
similar RNA labeling efficiency by the Bgl-mCherry and MS2-
YFP proteins (both ,92%; Table 1, Group 3 and 4).
Examination of viral particles generated from coexpression of
the Bgl and MS2 systems can determine the distribution of the
viral genomes at a single RNA level [21]. When both BglSL and
MS2SL containing HIV-1 genomes used the RRE element for
RNA transport, these two RNA species were copackaged together
efficiently (Table 1, Group 9); ,49% of the CeFP
+ particles have
both the mCherry and YFP signals (expected to be 50% by Hardy-
Weinberg equilibrium). Similarly, when both HIV-1 genomes used
the CTE element for RNA export, these RNA species were also
copackaged together efficiently; ,42% of the CeFP
+ particles have
both RNA signals (Table 1, Group 10). This finding agrees with
our recombination rate studies that efficient copackaging of HIV-1
RNA is not dependent on the CRM-1 transport pathway; two
RNA species transported by the NXF1 pathway can also
copackage together efficiently.
We then examined particles generated from coexpression of
HIV-1 genomes containing RRE or CTE. As shown in Table 1
(Group 11 and 12), RRE-containing HIV-1 RNA did not
copackage efficiently with CTE-containing HIV-1 RNA; most of
the CeFP
+ particles were labeled with one RNA signal, either
mCherry or YFP, and only ,22% of the CeFP
+ particles were
labeled with both YFP and mCherry signals regardless of whether
the RRE-containing RNA was detected by MS2-YFP or by Bgl-
mCherry. These results indicate that the RRE- and CTE-
containing RNAs were not copackaged together as frequently as
two RRE-containing RNAs or two CTE-containing RNAs. These
findings are in agreement with our data demonstrating a decreased
recombination rate between RRE- and CTE-containing HIV-1
variants (Fig. 3B).
Taken together, our results show that HIV-1 RNAs exported by
the CRM-1 and NXF1 pathways are not copackaged together
efficiently; therefore, RNA dimerization occurs at a point where
RNAs from the two pathways are partially segregated and not
completely mixed. However, both the recombination assay and
single virion analyses revealed that the RNAs transported by the
different pathways can still be copackaged, albeit less efficiently,
indicating a partial overlap of the RNAs from the two pathways at
the time of RNA dimerization and packaging.
The Effect of Nuclear Export Pathways on RNA Packaging
by Gag
The transport pathway used by the RNA encoding HIV-1 Gag
has been shown to affect the downstream assembly events in
rodent cells, indicating a link between RNA trafficking and protein
function [8,9]. Our results showed that RNAs using different
export pathways are not copackaged randomly; however, it was
unclear whether the use of different RNA export pathways also
affects the interaction between the RNA and viral Gag proteins,
thereby affecting the selection of packaged RNAs. If the RNA
export pathway dictates the location of Gag translation and
nascent Gag molecules favor the packaging of RNA within the
same locality, then Gag would be expected to demonstrate a
preference for packaging viral RNA exported via the same
pathway as that of the gag mRNA (Fig. 5A). Conversely, Gag could
demonstrate no preference for selecting and packaging viral RNA
exported by different pathways, irrespective of the transport
pathway used by its own mRNA.
To explore the impact of the RNA export pathway used by gag
mRNA, we generated a cell line infected with two viruses, H0-
CTE-Spe and T6-RRE-Spe (Fig. 1). Each of these viruses used a
different RNA transport pathway and contained an inactivating
frameshift mutation in gag. We then provided Gag in trans by
transfection of the cell line with various Gag-Pol expression
plasmids. The Gag-encoding mRNA is exported from the nucleus
by the CRM-1 pathway (RRE-Gag), the NXF1 pathway (CTE-
Gag), or both pathways (RRE-Gag and CTE-Gag). We then
compared the relative viral titers generated from these experi-
ments with those from the H0-CTE.T6-RRE cell line, in which
both viruses expressed functional Gag and the relative viral titers
were 44%:56% (HSA: Thy; 1
st lane Fig. 5B). If preferential
packaging occurred, we would expect to see an alteration in the
relative viral titers of the HSA and Thy viruses, with the direction
of the shift dependent on the export element used to provide Gag.
Alternatively, efficient trans-packaging across RNA transport
pathways would result in no alteration in the ratios of HSA:Thy
released from the H0-CTE-Spe.T6-RRE-Spe cell line.
Our results, summarized from three independent experiments,
demonstrate that the same relative levels of the two viruses (H0-
CTE-Spe and T6-RRE-Spe) were detected, irrespective of the
RNA export pathway used by the gag mRNA (Fig. 5B). Similar
results were obtained by infecting this cell line with a virus
Figure 4. General structures of the plasmids used for single
virion visualization. (A) Modified HIV-1 genomes used in the study.
Abbreviations are the same as Fig. 1. Stem loop sequences recognized
by BglG and MS2 coat proteins are shown in black and grey,
respectively; 18 Bgl stem loops and 24 MS2 stem loops are used in
these constructs although fewer stem loops are shown. (B) RNA binding
proteins tagged with fluorescent proteins used in the study. Pro, Pol II
promoter, NLS, nuclear localization signal, grey circle, transcription
termination signal.
doi:10.1371/journal.ppat.1000627.g004
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packages viral genomes with similar efficiency regardless of the
RNA transport pathways used by the full-length viral RNA or the
Gag mRNA. This observation further extends our previous
findings, demonstrating the ability of Gag to efficiently package
RNA in trans [24]. Moreover, we also observed that the resultant
recombination between the two Gag mutant viruses was
unaffected by the RNA transport pathway used by the supplied
Gag (Fig. 5C), indicating that the proportion of heterozygous
virions in the viral population was not altered. These results are
consistent with our previous observation that copackaged RNA
selection and dimerization occur prior to encapsidation into the
virion.
Discussion
The diverse roles played by the full-length HIV-1 RNA
necessitate strict control over each aspect of its biogenesis and
fate. Initially, newly synthesized RNA must be spliced for
expression of early gene products such as Rev and Tat. Once
Table 1. RNA contents in viral particles by Single virion visualization.
Group
Construct
tranfected
CeFP
+ particles
analyzed
% CeFP
+
& YFP
+
% CeFP
+
& mCherry
+
% CeFP
+ & YFP
+
& mCherry
+
RNA Labeling
efficiency
*
1 GagCeFP-BglSL-RRE + Bgl-mCherry
Exp.a 1668 0.0 97.7 0.0 97.7
Exp.b 931 0.0 95.7 0.1 95.8
2 GagCeFP-MS2SL-RRE + MS2-YFP
Exp.a 2042 93.0 0.0 0.0 93.0
Exp.b 1058 96.1 0.0 0.2 96.3
3 GagCeFP-BglSL-CTE + Bgl-mCherry
Exp.a 1193 0.0 92.6 0.0 92.6
Exp.b 479 0.0 90.8 0.2 91.0
4 GagCeFP-MS2SL-CTE + MS2-YFP
Exp.a 1540 90.5 0.0 0.0 90.5
Exp.b 533 92.9 0.0 0.2 93.1
5 GagCeFP-BglSL-RRE + MS2-YFP
Exp.a 664 0.3 0.0 0.0 0.3
Exp.b 1260 0.2 0.0 0.0 0.2
6 GagCeFP-MS2SL-RRE + Bgl-mCherry
Exp.a 410 0.0 0.0 0.0 0.0
Exp.b 649 0.0 0.0 0.0 0.0
Exp.c 304 0.0 0.0 0.0 0.0
7 GagCeFP-BglSL-CTE + MS2-YFP
Exp.a 633 0.5 0.0 0.0 0.5
Exp.b 239 0.0 0.0 0.0 0.0
Exp.c 368 0.8 0.0 0.0 0.8
8 GagCeFP-MS2SL-CTE + Bgl-mCherry
Exp.a 436 0.2 0.0 0.0 0.2
Exp.b 419 0.2 0.0 0.0 0.2
9 GagCeFP-BglSL-RRE + GagCeFP-MS2SL-RRE + Bgl-mCherry + MS2-YFP
Exp.a 962 28.3 18.0 50.7 97.0
Exp.b 986 22.4 21.8 47.1 91.3
10 GagCeFP-BglSL-CTE + GagCeFP-MS2SL-CTE + Bgl-mCherry + MS2-YFP
Exp.a 763 32.0 21.5 39.8 93.3
Exp.b 488 25.4 23.2 44.1 92.6
11 GagCeFP-BglSL-RRE + GagCeFP-MS2SL-CTE + Bgl-mCherry + MS2-YFP
Exp.a 713 48.1 21.3 21.6 91.0
Exp.b 517 33.8 39.1 22.2 95.2
12 GagCeFP-BglSL-CTE + GagCeFP-MS2SL-RRE + Bgl-mCherry + MS2-YFP
Exp.a 648 40.1 32.6 22.2 94.9
Exp.b 552 37.0 33.7 22.6 93.3
*RNA labeling efficiency is the sum of the three previous columns (%CeFP
+ &Y F P
+; % CeFP
+ & mCherry
+; % CeFP
+ &Y F P
+ & mCherry
+).
doi:10.1371/journal.ppat.1000627.t001
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RRE-containing transcripts, including the unspliced RNA. Once
in the cytoplasm, full-length viral RNA can be used for Gag/Gag-
Pol translation, or can be packaged into nascent particles as the
template for DNA synthesis in the next replication cycle. At least
two viral proteins, Rev and Gag, are involved in the trafficking of
the full-length RNA from the nucleus to the viral particle.
Additionally, interactions between the viral components and the
cellular pathways play a crucial role in the process, the extent and
specifics of which are not yet completely understood. Our findings
in this work provide an outline of events that lead to packaging of
the HIV-1 full-length RNAs. Following export from the nucleus,
HIV-1 full-length RNA selects its copackaged RNA partner by
forming base-pairing at the DIS. Our data demonstrated that the
initial dimerization event occurs in the cytoplasm, at a point where
RNA molecules exported from NXF1 and CRM-1 pathways are
not fully mixed. Although HIV-1 normally uses the CRM-1
transport pathway, this is not a prerequisite for efficient
copackaging of RNAs from two viruses; HIV-1 RNAs derived
from two viruses both using the NXF1 pathway for RNA transport
can also be efficiently copackaged. The dimeric RNAs then
interact with and are packaged by the Gag polyproteins;
furthermore, Gag expressed in trans can efficiently package HIV-1
RNAs exported using either the CRM-1 or the NXF1 pathway. In
addition to gaining an increased understanding of the HIV-1
replication cycle, our demonstration that RNAs from the NXF1
and CRM-1 pathways are partially segregated in specific cellular
locations also provides insights into the nuclear trafficking
pathways themselves.
Our finding that selection of HIV-1copackagedRNAs and initial
dimerization events mainly occur in the cytoplasm provide a
contrasttothesuggestednuclearMLVdimerizationevents[25–27].
The difference between these two viruses in the location of their
RNA dimerization event provides a possible explanation for the
stark difference in their respective recombination potentials. We
have directly compared the recombination rates of HIV-1 and
MLV using the same target sequences separated by 1 kb [13,28];
the HIV-1 rate under these conditions is 42.4%, whereas the MLV
rate is 10-fold lower at 4.7%, even though the reverse transcriptase
complex of each virus has a similar capacity to switch templates
during DNA synthesis [29–31]. As the initial dimerization event of
HIV-1occurs in the cytoplasm, the RNAs from twodifferent HIV-1
proviruses have a great opportunity to mix fully prior to
copackaging, thereby allowing efficient formation of heterozygous
virions and a high recombination potential. In contrast, MLV
appearstohavealimitedabilitytocopackageRNAsgenerated from
two separate proviruses. Although frequent crossovers can be
observed in MLV recombinants, only a limited number of viruses
are capable of generating phenotypically different recombinants. If,
as suggested, MLV RNA dimerizes within the nucleus, particularly
if it occurs at the site of transcription, then the RNA from two
proviruses would be unable to fully mix and heterozygous virions
would not be formed efficiently, reducing the recombination
potential of the viral population. Hence, the location of the initial
dimerization event may directly influence the recombination
potential and the ability of the virus to generate variation and
evolve. It is curious that two viruses from the same virus family
appear to initiate the dimerization events at rather different
locations. Interestingly, HIV-1 and MLV may also differ in whether
separate pools of RNAs are used for translation and RNA
packaging. Elegant early studies have suggested that MLV uses
two different pools of full-length RNAs, one for translation of Gag/
Gag-Pol and the other for encapsidation into newly synthesized
particles [32]. Such separation of RNA pools is not apparent for
HIV-1 [33,34]. We speculate that these differences may reflect
distinct strategies used by MLV and HIV-1 to regulate the function
of the full-length RNA. Experimental evidence supports that both
HIV-1 and MLV Gag package RNA dimers. Therefore, both
viruses have to face the dilemma of incompatibility between dimer
formation and ribosomal scanning through the dimeric region
during translation. We speculate that MLV solves this issue by using
early nuclear dimerization events to separate the two RNA pools
such that the packaged RNA is dimeric and the translated RNA is
monomeric. In contrast, HIV-1 adopts a different strategy, having
one pool of full-length RNA capable of translation, dimerization
and packaging [33,34]. Although the exact determinants of the fate
of each RNA are unclear, it is probable that dimerization within the
cytoplasm plays a key role in distinguishing RNA used for
translationfrom RNApackaged into virions.Both ofthese proposed
strategies bypass the conundrum of translating through dimerized
regions and maintain the dual role of the full-length genomic RNA.
In order to transport the full-length or singly spliced RNAs from
the nucleus to the cytoplasm, HIV-1 uses the cellular protein-
shuttling CRM-1 pathway instead of the NXF1-dependent
pathway. To determine the amount of overlap between these
two pathways and investigate the reliance of HIV-1 on its
Figure 5. Effect of nuclear export pathway used by gag mRNA
on genomic RNA packaging and recombination. (A) Schematic
representations of the expected outcomes when Gag is provided in
trans by mRNA using the CRM-1 pathway. (B) Proportion of the two
viruses released from the H0-CTE-Spe.T6-RRE-Spe cell line when Gag is
provided in trans by mRNA using either the CRM-1 or NXF1 pathway, or
both. The virus proportions when Gag is provided in cis are also shown
for comparison. (C) The recombination rate between the two viruses
when Gag is provided in trans. Means and standard deviation
generated from three experiments are shown.
doi:10.1371/journal.ppat.1000627.g005
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proviruses, we generated an RRE-independent HIV-1 that uses
the MPMV CTE and the NXF1 pathway for RNA export from
the nucleus. Using these viruses, we showed that the ability of
RNA from different HIV-1 proviruses to fully assort does not
depend on using the CRM-1 pathway. Furthermore, we showed
that the two pathways (CRM-1 and NXF1) are distinct at the point
of HIV-1 dimerization, although some recombination was
detected, indicating a partial overlap. To our knowledge, this is
the first time that an interaction between RNAs in these two
pathways has been addressed. The partial overlap between the
CRM-1 and NXF1 pathways also raises the interesting possibility
of RNA-RNA interactions between two differentially regulated
viruses, such as simian immunodeficiency virus and MPMV,
during the nuclear export of their full-length RNAs within dual-
infected cells.
Although the results presented here, which were generated from
three different cell lines, clearly and consistently indicate that the
recombination rates between an RRE- and a CTE-dependent
virus are lower than those from two viruses using the same RNA
transport pathway, it is worth noting that this lower recombination
rate was not consistently observed when viruses were produced by
cotransfection of an RRE- and a CTE-dependent viral DNA.
Viral titers generated by our transfection experiments are routinely
much higher than those from cell lines containing integrated
proviruses, most likely because high expression from multiple
copies of transfected DNA. We hypothesize that overexpression in
the transiently transfected cells can overload the system and blur
the boundaries between the two transport pathways. We believe
the results from the cell lines containing integrated proviruses most
closely mimic the events during HIV-1 replication in the human
population and are more biologically relevant than any transient
transfection data.
Using an HIV-1-based minimal vector and a helper construct, it
was recently shown that in the absence of the Rev-RRE
interaction, the level of vector RNA in the cytoplasm was slightly
reduced, but the virion RNA detected in the supernatant was
severely affected [35]. Therefore, the RRE-Rev interaction is
important for efficient RNA packaging. One possible explanation
is that cytoplasmic viral RNA was mistargeted in the absence of
functional RRE-Rev interaction and was unable to be efficiently
packaged by Gag. In our single virion analyses, the viral particles
derived from CTE-using HIV-1 contained viral RNA at similar
levels to those derived from RRE-using viruses (Table 1).
Additionally, we show that RRE- or CTE-containing RNA can
be packaged regardless of the RNA export pathway used by the
Gag-expressing RNA (Fig. 5). Together, these findings further
support the view that the RRE- or CTE-mediated RNA transport
pathway not only exports the RNA from the nucleus but also
targets these RNAs to proper compartments where downstream
events necessary for viral replication can occur.
Why some retroviruses, such as HIV-1, have evolved a
dependence on the CRM-1 pathway whereas other retroviruses,
such as MPMV, use the NXF1 pathway remains a mystery.
However, the use of two differentially exported HIV-1 viruses
within the same coinfected cell line provides a unique tool to
analyze this and many other questions. Moreover, the two
pathways could be further dissected to define novel cellular factors
involved in RNA trafficking, which may lead to the identification
of novel targets for the development of antiviral compounds
specific for HIV-1 RNA export. This cell line might also provide a
basis for a high-throughput screen to identify antiviral compounds
that specifically target the interplay of HIV-1 RNA with the
CRM-1 pathway.
Materials and Methods
Viral Constructs
For clarity, previously described pON-H0 and pON-T6 [13]
are referred to as H0-RRE and T6-RRE, respectively. T6-NC*
and H0-PTAP
– contain a CCHC/CCHC-to-CCHH/CCCC
mutation in NC and a PTAP-to-LIRL mutation in p6,
respectively. H0-DRRE was derived from H0-RRE by deleting
the entire RRE (nt 7644–8330 in NL4-3). H0-CTE was generated
by inserting a DNA fragment containing four copies of the MPMV
CTE (4XCTE) obtained from pGPV-CTEx4 [8] into H0-DRRE
at the location of the previously removed RRE. B6-RRE was
derived from T6-RRE by replacing thy with mouse B7 gene; B6-
CTE was generated by replacing the NotI-to-XhoI fragment of
H0-CTE with that of B6-RRE. T6-RRE-Spe and H0-CTE-Spe
each contains a premature stop in gag located in the middle of the
CA domain. RNA derived from H0-Spe, which has identical
structure as H0-RRE except containing the aforementioned
premature gag stop codon mutation were packaged at a similar
efficiency to RNA derived from H0-RRE [24].
Plasmid MS2-YFP was a gift from Robert Singer [36]; Bgl-
mCherry has been recently described [21]. For clarity, the
previously described GagCeFP-MS2SL and GagCeFP-BglSL
[21] are referred to as GagCeFP-MS2SL-RRE and GagCeFP-
BglSL-RRE, respectively. These modified NL43-based HIV-1
genomes encode functional gag, tat and rev, and cis-acting elements
such as LTRs, 59 untranslated regions, and RRE; however, they
have inactivating deletions in pol, vif, vpr, vpu, and env. To generate
GagCeFP-MS2SL-CTE and GagCeFP-BglSL-CTE, a CTE-
containing DNA fragment from B6-CTE was used to replace
the corresponding RRE-containing DNA fragment in GagCeFP-
MS2SL-RRE and GagCeFP-BglSL-RRE, respectively, using a
two-step cloning process. The general structures of newly
generated vectors were characterized by restriction enzyme
mapping; inserted fragments that were amplified by PCR were
verified by DNA sequencing.
Cell Culture, Recombination Assay and Fusion Assay
The cell line 293T.CC, a kind gift from Dr. Robert Doms, is a
derivative of the 293T cell line that expresses CD4 and CCR5.
Hut/CCR5 and 293T cells were maintained as described
previously [15]. Transfection of 293T cells was performed with
the TransIT-LT1 reagent (Mirrus).
Cell lines containing two proviruses were produced as
previously described [13] by sequential infection of viruses at
low MOIs, followed by multiple rounds of cell sorting. To measure
virus titers and recombination rates, viruses were harvested from
producer cell lines transfected with the HIV-1 Env-expressing
plasmid pIIINL(AD8) [37] and used to infect Hut/CCR5 target
cells. Marker gene expression of target cells was detected by flow
cytometry using cell staining with antibodies [13]. Infected cells
were identified by expression of encoded markers (HSA, Thy, or
B7), whereas cells infected with recombinant viruses were
identified by the GFP
+ phenotype using flow cytometry. The
numbers of infected cells or cells infected with recombinants in the
population were then converted to MOI using the Poison
distribution. Recombination rates were calculated as the MOI of
GFP
+ cells divided by the MOI of infected cells. Additionally,
infections were carried out at relatively low MOI when each
parental viral titer was less than 0.5 and a minimum of 750 GFP
+
cells were sampled in each measured rate.
To generate the cell lines used for the fusion assay,
pseuodotyped viruses containing T6-NC* or H0-PTAP
– genomes
were produced by cotransfection with helper plasmids expressing
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293T.CC cells separately; provirus-containing cells, identified by
their expression of HSA or Thy marker, were enriched by two to
three rounds of cell sorting. To perform the fusion assay, the
provirus-containing 293T-based cell line was transfected with
pIIINL(AD8). The provirus-containing 293T.CC-based cell line
were cocultured with equal numbers of successfully transfected
293T cells at 24 h posttransfection. Viruses were harvested from
the coculture 16 h after mixing the two cell lines, clarified through
a 0.45-mm-pore-size filter, and used to infect Hut/CCR5 cells by
spinnoculation (12006g for 1 h at 15uC) in the presence of 10 mg/
ml polybrene. Where indicated, the mixed cells were cultured in
the presence of roscovitine, added at the time of mixing, at a final
concentration of 10 mM.
Single Virus Visualization
Human 293T cells were maintained as described above;
transient transfection was performed with FuGENE HD (Roche)
according to the manufacturer’s recommendation. For all
visualization experiments, 293T cells were cotransfected with a
pair of modified HIV-1 plasmid DNA, one expressing GagCeFP
and the other wild-type Gag at equal weight ratios; although only
the plasmid with GagCeFP was mentioned for concise description.
Virus particles were harvested 17 h posttransfection, and clarified
by filtration as described above. To visualize particles, polybrene
was added to the culture supernatant (25 mg/ml final concentra-
tion); this mixture was placed in a glass-bottom dish and incubated
for 2 h at 37uC with 5% CO2 before image acquisition.
Epifluorescence microscopy was performed with an inverted
Nikon TE2000E2 microscope and a 10061.40 numerical aperture
oil objective, using an X-Cite 120 system (EXFO Photonic
Solution Inc.) for illumination. Digital images were acquired using
a Hammamatsu ORCA-ER camera and Openlab software
(Improvision) with the excitation and emission filter sets 427/
10 nm and 472/30 nm for CeFP, 504/12 nm and 542/27 nm for
YFP, and 577/25 nm and 632/60 nm for mCherry, respectively.
Virus particle and RNA signal analysis and colocalization were
performed by using custom software developed with Matlab
TM
and dipimage as previously described [21]. Merged images and
pseudo-colored images were generated using ImageJ software.
Supporting Information
Figure S1 Cell fusion without nuclear fusion. The cell line
293T.CC, expressing CD4 and CCR5, was mixed with 293T cells,
which were transiently transfected with a plasmid encoding a
CCR5 tropic HIV-1 Env. These two types of cells were mixed at
equal ratios and were incubated for 16 hours in the presence of
roscovitine prior to fixing. Prior to mixing the two cell types, the
293T cells were stained green with SYTO 11 (shown in panel A)
and the 293TCC cells were stained red with SYTO 64 (shown in
panel B). Nuclei were stained blue using Hoechst 33342 (panel C).
Large, fused multinucleated cells appeared positive for both red
and green (central large cell) and distinct nuclei (arrows, panel D)
were observed in these fusion experiments demonstrating that
these cells were fused but each nucleus remained intact at
16 hours.
Found at: doi:10.1371/journal.ppat.1000627.s001 (2.33 MB PDF)
Figure S2 Representative flow cytometry analysis of cells
infected with the HIV-1 vector BIG reveals efficient co-expression
of B7 and GFP markers. BIG is identical to B6-RRE (shown in
Fig. 1) except it contains a functional gfp gene. The two marker
genes, B7 and gfp, are located in the nef reading frame; the
translation of gfp is directed by an IRES.
Found at: doi:10.1371/journal.ppat.1000627.s002 (0.29 MB PDF)
Figure S3 Representative images of RNAs in single virions. In
these images, Gag is detected with the CeFP signal, BglSL-
containing HIV-1 RNA is detected with the mCherry signal, and
MS2SL-containing HIV-1 RNA is detected with the YFP signal.
Viral particles generated from cotransfection of GagCeFP-
MS2SL-CTE and MS2-YFP (A), GagCeFP-MS2SL-CTE, Gag-
CeFP-BglSL-CTE, MS2-YFP and Bgl-mCherry (B), and Gag-
CeFP-MS2SL-CTE, GagCeFP-BglSL-RRE, MS2-YFP, and Bgl-
mCherry (C). The channels used to detect these images are shown
on top of each panel. To better demonstrate colocalization of
signals, a merged and shifted panel was generated for each set of
the images; in this panel, images captured from different channels
were merged and the signals from the YFP channel were shifted by
4 pixels and signals from the mCherry channel were shifted by 8
pixels.
Found at: doi:10.1371/journal.ppat.1000627.s003 (0.19 MB PDF)
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